SE7809907L - Mellanprodukter for anvendnig vid framstellning av farmaceutiskt anvendbara foreningar - Google Patents

Mellanprodukter for anvendnig vid framstellning av farmaceutiskt anvendbara foreningar

Info

Publication number
SE7809907L
SE7809907L SE7809907A SE7809907A SE7809907L SE 7809907 L SE7809907 L SE 7809907L SE 7809907 A SE7809907 A SE 7809907A SE 7809907 A SE7809907 A SE 7809907A SE 7809907 L SE7809907 L SE 7809907L
Authority
SE
Sweden
Prior art keywords
manufacture
intermediate products
pharmaceutical uses
pharmaceutical
products
Prior art date
Application number
SE7809907A
Other languages
English (en)
Swedish (sv)
Inventor
F Cassidy
G Wootton
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7809907L publication Critical patent/SE7809907L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
SE7809907A 1974-11-29 1978-09-20 Mellanprodukter for anvendnig vid framstellning av farmaceutiskt anvendbara foreningar SE7809907L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51733/74A GB1524818A (en) 1974-11-29 1974-11-29 12-azaprostaglandins

Publications (1)

Publication Number Publication Date
SE7809907L true SE7809907L (sv) 1978-09-20

Family

ID=10461163

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7513255A SE413505B (sv) 1974-11-29 1975-11-25 Forfarande for framstellning av cykliska aminer och amider med farmaceutisk aktivitet
SE7809907A SE7809907L (sv) 1974-11-29 1978-09-20 Mellanprodukter for anvendnig vid framstellning av farmaceutiskt anvendbara foreningar

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7513255A SE413505B (sv) 1974-11-29 1975-11-25 Forfarande for framstellning av cykliska aminer och amider med farmaceutisk aktivitet

Country Status (19)

Country Link
US (1) US4299970A (xx)
JP (1) JPS51125278A (xx)
AT (1) AT359216B (xx)
AU (2) AU496753B2 (xx)
BE (1) BE835989A (xx)
CA (1) CA1088062A (xx)
CH (2) CH626325A5 (xx)
DE (1) DE2552312A1 (xx)
DK (1) DK539775A (xx)
ES (1) ES443081A1 (xx)
FI (1) FI753341A (xx)
FR (2) FR2313043A1 (xx)
GB (1) GB1524818A (xx)
HU (2) HU176752B (xx)
IE (1) IE41877B1 (xx)
NL (1) NL7513903A (xx)
NO (2) NO753935L (xx)
SE (2) SE413505B (xx)
ZA (1) ZA757121B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362839A1 (fr) * 1976-06-03 1978-03-24 Wellcome Found Derives de l'hydantoine et medicaments contenant ces substances
IL53559A0 (en) 1976-12-18 1978-03-10 Beecham Group Ltd Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them
EP0007180B1 (en) * 1978-06-15 1983-03-30 Beecham Group Plc Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them
AU4806879A (en) * 1978-06-15 1979-12-20 Beecham Group Limited 1,2,4 triazole derivatives
IL58384A0 (en) * 1978-10-14 1980-01-31 Beecham Group Ltd 12-aza analogues of prostcyclin their preparation and pharmaceutical composition containing them
US6211226B1 (en) * 1998-12-17 2001-04-03 Alcon Laboratories, Inc. 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
WO2003103604A2 (en) * 2002-06-01 2003-12-18 Applied Research Systems Ars Holding N.V Gamma lactams as prostaglandin agonists and use thereof
US7053085B2 (en) * 2003-03-26 2006-05-30 Merck & Co. Inc. EP4 receptor agonist, compositions and methods thereof
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
US7696243B2 (en) * 2004-12-06 2010-04-13 Merck Serono, S.A. Pyrrolidin-2-one derivatives for use as DP1 receptor agonists
WO2023212495A1 (en) * 2022-04-29 2023-11-02 Zymergen Inc. Novel bio-based compound, method of forming the compound, and adhesive compositions containing the novel compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2343769A (en) * 1941-09-27 1944-03-07 Du Pont Aliphatic aminoacyl compound and method for preparing same
US2582257A (en) * 1950-09-15 1952-01-15 Parke Davis & Co Esters and methods for obtaining the same
NZ182263A (en) * 1975-10-25 1979-01-11 Beecham Group Ltd 2-carboxyalkyl-4,4-dimethyl-1-hydroxy-alkyl-pyrrolidin-3,5-dione derivativesand pharmaceutical compositions
NZ182264A (en) * 1975-10-25 1979-01-11 Beecham Group Ltd 2-carboxyalkyl-1-hydroxyalkyl-pyrrolidin-3,5-dione or-piperidin-3,6-dione derivatives prarmaceutical compostions
US4201864A (en) * 1975-10-25 1980-05-06 Beecham Group Limited Oxy-alkylamino acids and esters

Also Published As

Publication number Publication date
GB1524818A (en) 1978-09-13
FR2379510A1 (fr) 1978-09-01
SE413505B (sv) 1980-06-02
DK539775A (da) 1976-05-30
ATA898375A (de) 1980-03-15
AU8710775A (en) 1977-06-02
HU174537B (hu) 1980-02-28
AU3942778A (en) 1980-03-06
ZA757121B (en) 1976-10-27
SE7513255L (sv) 1976-05-31
HU176752B (en) 1981-05-28
US4299970A (en) 1981-11-10
IE41877L (en) 1976-05-29
ES443081A1 (es) 1977-05-01
IE41877B1 (en) 1980-04-09
JPS51125278A (en) 1976-11-01
FI753341A (xx) 1976-05-30
CA1088062A (en) 1980-10-21
NO753935L (xx) 1976-06-01
FR2313043A1 (fr) 1976-12-31
BE835989A (fr) 1976-05-26
FR2379510B1 (xx) 1982-10-29
AU496753B2 (en) 1978-10-26
NO783765L (no) 1976-06-01
FR2313043B1 (xx) 1982-08-13
NL7513903A (nl) 1976-06-01
CH626325A5 (xx) 1981-11-13
AT359216B (de) 1980-10-27
CH629748A5 (de) 1982-05-14
AU526356B2 (en) 1983-01-06
DE2552312A1 (de) 1976-08-12

Similar Documents

Publication Publication Date Title
DOP1980002892A (es) Composicion farmaceutica
SE390967B (sv) Tiokarbamider till anvendning som mellanprodukter vid framstellning av isotiokarbamider med farmaceautisk verkan
AT358716B (de) Arzneimittel- oder kosmetikbehaelter
SE404212B (sv) For anvendning vid bildande av en bandgallerstruktur avsett vagigt band
SE430605B (sv) Forening for anvendning som mellanprodukt vid framstellning av ftalidestrar av penicilliner
FR2282259A1 (fr) Medicament sous forme de grains friables
SE436278B (sv) Cyklopentanderivat for anvendning sasom intermediat vid framstellning av prostaglandinforeningar
SE7509566L (sv) Blasmedelsblandning till anvendning vid framstellning av skumplaster
SE7809907L (sv) Mellanprodukter for anvendnig vid framstellning av farmaceutiskt anvendbara foreningar
FI56071C (fi) Anordning foer manoevrering av luftreglerdon vid avfallsfoerbraenningsugnar
SE458766B (sv) Mellanprodukt till anvaendning vid framstaellning av 2,4,6-triaminopyrimidin-3-oxider, vilken mellanprodukt utgoeres av en 3-cyanimino-3-aminopropionitril samt foerfarande foer framstaellning av naemnda mellanprodukt
FI773346A (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara aminopropanolderivat
SE413020B (sv) Konstgodsel av isobutylidenkarbamid
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
IT1010763B (it) Procedimento e dispositivo per la fabbricazione di materiali in fo glio od in pezza
SE7700287L (sv) Nya foreningar till anvendning som mellanprodukter vid framstellning av aminosubstituerade tetracykliska foreningar
SE418182B (sv) Oxatiino-och ditiinoaminoettiksyror till anvendning vid framstellning av terapeutiskt verksamma cefalosporinderivat
SE406910B (sv) Alfa-sulfofonylettiksyraderivat till anvendning sonm mellanprodukt vid framstellning av motsvarande alfa-sulfobensylpenicilliner
BE832277R (fr) Nouvelles piperazilo-pyrimidines utilisables comme medicaments
BE769609A (fr) Nouveaux composes cepheme utiles comme medicaments
FR2285871A1 (fr) Compositions pharmaceutiques
ZA741259B (en) Pharmaceutical compositions and methods of using the same
NL7408611A (nl) Amiden van dihydroapovincaminezuur en farmaceu- tische toepassing daarvan.
SE7806349L (sv) Mellanprodukter avsedda for framstellning av trien-steroidderivat
SE7713835L (sv) Forfarande for framstellning av 1alfa-hydroxicholekalciferol och mellanprodukter for anvendning i forfarandet